8964 Federal Register / Vol. 74, No. 38 / Friday, February 27, 2009 / Notices 

attendants meet the capacity of the 

room, the meeting will be closed. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both CDC 

and the Agency for Toxic Substances 

and Disease Registry. 

Dated: February 13, 2009. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention (CDC). 

[FR Doc. E9–4204 Filed 2–26–09; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[Document Identifier: CMS–10237 and 

10214, and CMS–10171] 

Agency Information Collection 

Activities: Proposed Collection; 

Comment Request 

AGENCY: Centers for Medicare & 

Medicaid Services, HHS. 

In compliance with the requirement 

of section 3506(c)(2)(A) of the 

Paperwork Reduction Act of 1995, the 

Centers for Medicare & Medicaid 

Services (CMS) is publishing the 

following summary of proposed 

collections for public comment. 

Interested persons are invited to send 

comments regarding this burden 

estimate or any other aspect of this 

collection of information, including any 

of the following subjects: (1) The 

necessity and utility of the proposed 

information collection for the proper 

performance of the agency’s functions; 

(2) the accuracy of the estimated 

burden; (3) ways to enhance the quality, 

utility, and clarity of the information to 

be collected; and (4) the use of 

automated collection techniques or 

other forms of information technology to 

minimize the information collection 

burden. 

1. Type of Information Collection 

Request: Extension of a currently 

approved collection; Title of 

Information Collection: Medicare 

Advantage Applications—Part C and 

regulations under 42 CFR part 422 

subpart K; Use: The Balanced Budget 

Act of 1997 established a new ‘‘Part C’’ 

in the Medicare statute Social Security 

Act (the Act), which provided for a 

Medicare+Choice (M+C) program. 

Under section 1851 of the Act, every 

individual entitled to Medicare Part A 

and enrolled under Part B, except for 

most individuals with end-stage renal 

disease (ESRD), could elect to receive 

benefits either through the Original 

Medicare Program or an M+C plan. 

The Medicare Prescription Drug, 

Improvement, and Modernization Act of 

2003 (MMA) was enacted on December 

8, 2003. The MMA established the 

Medicare Prescription Drug Benefit 

Program (Part D) and made revisions to 

the provisions of Medicare Part C, 

governing what is now called the 

Medicare Advantage (MA) program 

(formerly Medicare+Choice). 

Coverage for the prescription drug 

benefit is provided through contracted 

prescription drug plans or through 

Medicare Advantage (MA) plans that 

offer integrated prescription drug and 

health care coverage (MA–PD plans). 

Cost plans that are required under 

section 1876 of the Social Security Act, 

and Employer Group Waiver Plans 

(EGWP) may also provide a Part D 

benefit. Organizations wishing to 

provide services under the MA and 

MA–PD plans must complete an 

application, negotiate rates and receive 

final approval from CMS. Certain 

existing MA plans may also expand 

their contracted area by completing the 

Service Area Expansion (SAE) 

application. 

Form Number: CMS–10237 and 10214 

(OMB# 0938–0935); Frequency: Yearly; 

Affected Public: Private Sector; Number 

of Respondents: 267; Total Annual 

Responses: 267; Total Annual Hours: 

6,490. (For policy questions regarding 

this collection contact Betty Burrier at 

410–786–4649. For all other issues call 

410–786–1326.) 

2. Type of Information Collection 

Request: Revision of a currently 

approved collection; Title of 

Information Collection: Coordination of 

Benefits between Part D Plans and Other 

Prescription Coverage Providers; Use: 

Section 1860D–23 and 1860D–24 of the 

Social Security Act requires the 

Secretary to establish requirements for 

prescription drug plans to ensure the 

effective coordination between Part D 

plans, State pharmaceutical Assistance 

programs and other payers. This 

collection request will assist CMS, Part 

D plans and other payers with 

coordination of prescription drug 

benefits at the point-of-sale and tracking 

of the beneficiary’s True out-of-pocket 

(TrOOP) expenditures using the TrOOP 

facilitator. This information will be used 

by Part D plans, other health insurers or 

payers, pharmacies and CMS to 

coordinate prescription drug benefits 

provided to the Medicare beneficiary. 

Beginning in CY 2009, CMS, via the 

TrOOP facilitation contractor, will 

automate the transfer of beneficiary 

coverage information when a 

beneficiary changes plans. Form 

Number: CMS–10171 (OMB# 0938– 

0978); Frequency: Hourly, yearly and 

occasionally; Affected Public: Business 

or other for-profits; Number of 

Respondents: 56,988; Total Annual 

Responses: 1,139,760; Total Annual 

Hours: 1,125,883. (For policy questions 

regarding this collection contact 

Christine Hinds at 410–786–4578. For 

all other issues call 410–786–1326.) 

To obtain copies of the supporting 

statement and any related forms for the 

proposed paperwork collections 

referenced above, access CMS’ Web site 

at http://www.cms.hhs.gov/ 

PaperworkReductionActof1995, or email your request, including your 

address, phone number, OMB number, 

and CMS document identifier, to 

Paperwork@cms.hhs.gov, or call the 

Reports Clearance Office on (410) 786– 

1326. 

In commenting on the proposed 

information collections please reference 

the document identifier or OMB control 

number. To be assured consideration, 

comments and recommendations must 

be submitted in one of the following 

ways by April 28, 2009: 

1. Electronically. You may submit 

your comments electronically to http:// 

www.regulations.gov. Follow the 

instructions for ‘‘Comment or 

Submission’’ or ‘‘More Search Options’’ 

to find the information collection 

document(s) accepting comments. 

2. By regular mail. You may mail 

written comments to the following 

address: CMS, Office of Strategic 

Operations and Regulatory Affairs, 

Division of Regulations Development, 

Attention: Document Identifier/OMB 

Control Number, Room C4–26–05, 7500 

Security Boulevard, Baltimore, 

Maryland 21244–1850. 

Dated: February 20, 2009. 

Michelle Shortt, 

Director, Regulations Development Group, 

Office of Strategic Operations and Regulatory 

Affairs. 

[FR Doc. E9–4128 Filed 2–26–09; 8:45 am] 

BILLING CODE 4120–01–P 


rwilkins on PROD1PC63 with NOTICES2